Moreover, YBX1 enhanced EGFR transcription by directly binding to its promoter in chordoma cells, thereby regulating protein expression of p-EGFR, p-AKT and its downstream target genes that influence cell apoptosis and cell cycle transition [25]. The gene discussed is EGFR; the disease is chordoma.